Fibronectin is required for integrin αvβ6-mediated activation of latent TGF-β complexes containing LTBP-1

被引:140
作者
Fontana, L
Chen, Y
Prijateli, P
Sakai, T
Fässler, R
Sakai, LY
Rifkin, DB
机构
[1] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA
[2] NYU, Sch Med, Dept Med, New York, NY 10016 USA
[3] Oregon Hlth & Sci Univ, Shriners Hosp Children, Portland, OR 97201 USA
[4] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97201 USA
[5] Max Planck Inst Biochem, D-82152 Martinsried, Germany
[6] Dept Mol Med, Martinsried, Germany
关键词
LTBP; TGF-beta; fibronectin null cells;
D O I
10.1096/fj.05-4134com
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Transforming growth factor-beta s (TGF-beta) are secreted as latent complexes consisting of the TGF-beta dimer, the TGF-beta propeptide dimer, and the latent TGF-beta binding protein ( LTBP). Although the bonds between TGF-beta and its propeptide are cleaved intracellulary, the propeptide associates with TGF-beta by electrostatic interactions, thereby conferring latency to the complex. We reported that a specific sequence of LTBP-1 is required for latent TGF-beta activation by the integrin alpha v beta 6. Here we describe a 24 amino acid sequence from the hinge domain required for activation. The LTBP-1 polypeptide rL1N, which includes the hinge, associates with fibronectin in binding assays. We present evidence that fibronectin null cells minimally activate latent TGF-beta and poorly incorporate the active hinge sequence into their matrix. In addition, cells missing the fibronectin receptor alpha 5 beta 1 exhibit defective activation of latent TGF-beta by alpha v beta 6 and decreased matrix incorporation. The results indicate specificity for integrin-mediated latent TGF-beta activation that include unique sequences in LTBP-1 and an appropriate matrix molecule.
引用
收藏
页码:1798 / 1808
页数:11
相关论文
共 58 条
[1]   AN ASSAY FOR TRANSFORMING GROWTH-FACTOR-BETA USING CELLS TRANSFECTED WITH A PLASMINOGEN-ACTIVATOR INHIBITOR-1 PROMOTER LUCIFERASE CONSTRUCT [J].
ABE, M ;
HARPEL, JG ;
METZ, CN ;
NUNES, I ;
LOSKUTOFF, DJ ;
RIFKIN, DB .
ANALYTICAL BIOCHEMISTRY, 1994, 216 (02) :276-284
[2]   Integrin αvβ6-mediated activation of latent TGF-β requires the latent TGF-β binding protein-1 [J].
Annes, JP ;
Chen, Y ;
Munger, JS ;
Rifkin, DB .
JOURNAL OF CELL BIOLOGY, 2004, 165 (05) :723-734
[3]   Making sense of latent TGFβ activation [J].
Annes, JP ;
Munger, JS ;
Rifkin, DB .
JOURNAL OF CELL SCIENCE, 2003, 116 (02) :217-224
[4]   TRANSFORMING GROWTH-FACTOR BETA-REGULATES THE LEVELS OF DIFFERENT FIBRONECTIN ISOFORMS IN NORMAL HUMAN CULTURED FIBROBLASTS [J].
BALZA, E ;
BORSI, L ;
ALLEMANNI, G ;
ZARDI, L .
FEBS LETTERS, 1988, 228 (01) :42-44
[5]   Mechanisms of disease:: Role of transforming growth factor β in human disease. [J].
Blobe, GC ;
Schiemann, WP ;
Lodish, HF .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (18) :1350-1358
[6]   Physicochemical Activation of Recombinant Latent Transforming Growth Factor-beta's 1, 2, and 3 [J].
Brownh, Peter D. ;
Wakefiel, Lalage M. ;
Levinson, Arthur D. ;
Sporn, Michael B. .
GROWTH FACTORS, 1990, 3 (01) :35-43
[7]   TGF-β1 modulated the expression of α5β1 integrin and integrin-mediated signaling in human hepatocarcinoma cells [J].
Cai, T ;
Lei, QY ;
Wang, LY ;
Zha, XL .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 274 (02) :519-525
[8]  
Collo G, 1999, J CELL SCI, V112, P569
[9]   Fibronectin regulates latent transforming growth factor-β (TGFβ) by controlling matrix assembly of latent TGFβ-binding protein-1 [J].
Dallas, SL ;
Sivakumar, P ;
Jones, CJP ;
Chen, Q ;
Peters, DM ;
Mosher, DF ;
Humphries, MJ ;
Kielty, CM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (19) :18871-18880
[10]   Role of the latent transforming growth factor β binding protein 1 in fibrillin-containing microfibrils in bone cells in vitro and in vivo [J].
Dallas, SL ;
Keene, DR ;
Bruder, SP ;
Saharinen, J ;
Sakai, LY ;
Mundy, GR ;
Bonewald, LF .
JOURNAL OF BONE AND MINERAL RESEARCH, 2000, 15 (01) :68-81